Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – As long as eligibility criteria are strictly followed, it is safe to let “real world” patients undergoing percutaneous coronary intervention go home on…
NEW YORK (Reuters Health) – The use of angiotensin blocking therapy before cardiac surgery is not associated with postoperative atrial fibrillation (AF), researchers report in the August American…
NEW YORK (Reuters Health) – In high-risk patients having percutaneous coronary intervention for ST-segment elevation acute myocardial infarction (STEMI), bivalirudin was more effective than unfractionated heparin plus a…
NEW YORK (Reuters Health) – Coronary heart disease that continues to progress to serious events in patients whose LDL levels have been brought down adequately — called “residual…
NEW YORK (Reuters Health) – Recommendations issued by the European Society of Cardiology emphasize the need to consider the clinical context in interpreting cardiac troponin readings in acute…
NEW YORK (Reuters Health) – Very elderly patients with ST-segment elevation MI can do quite well with successful primary percutaneous intervention, as long they aren’t in cardiogenic shock…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who receive timely guideline-based reperfusion therapy — fibrinolysis within 30 minutes of arrival and primary percutaneous coronary…
NEW YORK (Reuters Health) – In patients with ST-segment elevation myocardial infarction (STEMI), most of the benefits of sirolimus-eluting stents over bare-metal stents accrue during the first year…
NEW YORK (Reuters Health) – Compared to a modified Blalock-Taussig (MBT) shunt, a right ventricle-pulmonary artery (RV-PA) shunt achieves higher 12-month transplant-free survival in babies with hypoplastic left…
NEW YORK (Reuters Health) – Superficial, or “nuisance,” bleeding troubled more than a quarter of patients on dual-antiplatelet therapy following the implantation of drug-eluting stents, according to new…
